$16.49 $0.54 per serving
Product analysis
Ubiquinol 200 mg Maximum Strength is an inexpensive option that may support blood-vessel function or fatigue in selected adults. Everyday benefits in healthy adults remain uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Preparation details are not clearly disclosed in the ingredient declaration. That limits a close comparison of CoQ10 quality and absorption.
Ingredient Transparency63
The CoQ10 amount is stated. The ingredient declaration does not clearly specify its form, limiting precise preparation comparisons.
Value For Money100
The CoQ10 compares favorably on cost for the amount supplied. That supports price value while leaving preparation details as a separate question.
Customer Satisfaction86
Customer feedback is very positive across more than a thousand ratings. The review history gives useful satisfaction context without proving cardiovascular or fatigue benefits.
Product Focus80
The clearest support concerns blood-vessel function and possible fatigue relief in selected groups. The wider metabolism, inflammation and longevity aims remain uncertain.
- Format
Softgel - Container
- 30 Softgel(s)
- Per serving
- $0.54
- Also available
Ubiquinol 50 mg$14.99- Customer rating
- 4.9 · 1,154 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Ubiquinol has limited support for improving a measure of endothelial function in adults with dyslipidemia and endothelial dysfunction. A small eight-week trial tested 100 and 200 mg/day, without establishing dose superiority or cardiovascular-event prevention. The declared serving receives full amount recognition, but does not establish the same daily regimen or finished-product equivalence.
How this product is rated for Heart Health
Ingredient fit93
The relevant ingredients are relatively focused on heart-health aspects. The counted amounts receive full recognition; this does not establish additional cardiovascular benefit from increasing them.
Goal fit
The relevant ingredients are relatively focused on heart-health aspects.
Dose adequacy
The counted amounts receive full recognition; this does not establish additional cardiovascular benefit from increasing them.
Pathways60
The relevant ingredient contribution is assigned to endothelial vascular function; this does not establish clinical-event prevention. Only one evaluated pathway meets the breadth threshold.
Depth
The relevant ingredient contribution is assigned to endothelial vascular function; this does not establish clinical-event prevention.
Breadth
Only one evaluated pathway meets the breadth threshold.
Evidence98
Coenzyme Q-10 leads the saved finding. The counted preparations receive recognition, without proving the same population, duration or clinical outcome.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; clinical interpretation remains specific to the ingredient and outcome.
Studied preparation
The counted preparations receive recognition, without proving the same population, duration or clinical outcome.
Formulation logic100
Each counted ingredient works independently or has its required partner; no extra combined benefit is established. No configured conflict was matched.
Partner coverage
Each counted ingredient works independently or has its required partner; no extra combined benefit is established.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients meet the amount inclusion criterion, which is distinct from a clinically proven prevention threshold.
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
CoQ10 at 200 mg relates to cellular energy production and antioxidant activity. The supplied human findings on visible skin aging concern a specific water-soluble preparation, so the unmatched preparation here gives only a limited basis for expecting those effects; a longer lifespan is not an established benefit.
How this product is rated for Longevity
Ingredient fit93
The relevant ingredients are focused on the assessed aspects of healthy aging. The saved assessment finds the relevant declared amounts sufficient for its comparison.
Goal fit
The relevant ingredients are focused on the assessed aspects of healthy aging.
Dose adequacy
The saved assessment finds the relevant declared amounts sufficient for its comparison.
Pathways40
The strongest assessed connection is mitochondrial energy production, with a meaningful but partial contribution. The meaningful contribution is concentrated in one assessed aging-related function.
Depth
The strongest assessed connection is mitochondrial energy production, with a meaningful but partial contribution.
Breadth
The meaningful contribution is concentrated in one assessed aging-related function.
Evidence30
Coenzyme Q-10 supplies the leading relevant evidence, which should not be read as evidence of longer life. The declared material is unmatched to the specific studied preparation in the saved assessment.
Evidence strength
Coenzyme Q-10 supplies the leading relevant evidence, which should not be read as evidence of longer life.
Studied preparation
The declared material is unmatched to the specific studied preparation in the saved assessment.
Formulation logic100
The assessed ingredients can contribute on their own or have their required partner. No configured ingredient conflict was identified in the supplied assessment. 1 of 1 assessed ingredients meet the saved minimum amount threshold
Partner coverage
The assessed ingredients can contribute on their own or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Ubiquinol is a form of CoQ10 with limited support for blood-vessel lining function in people with dyslipidemia and endothelial dysfunction. The 200 mg serving matches the saved amount comparison for this identified preparation. Small studies concern vascular markers, rather than established prevention of cardiovascular events. The supplied evidence does not establish that ubiquinol is superior to other CoQ10 forms.
How this product is rated for Cardiovascular Support
Ingredient fit93
The formula focuses on identified CoQ10, with a qualifying amount.
Goal fit
CoQ10 is the sole active ingredient and provides a focused connection to vessel function.
Dose adequacy
The 200 mg ubiquinol serving meets the saved preparation-specific amount comparison.
Pathways60
The contribution centers on the function of the blood-vessel lining. Other evaluated cardiovascular processes receive none.
Depth
CoQ10 contributes to the nitric-oxide-related vessel-lining function finding.
Breadth
Vessel-lining function is the only substantially represented process.
Evidence88
Identified ubiquinol has limited vascular-marker support from a small study in people with dyslipidemia and vessel dysfunction.
Evidence strength
CoQ10 provides support for selected vascular markers, not proven prevention of cardiovascular events.
Studied preparation
The contributing preparations were recognized in the saved findings; this does not establish superiority over other forms.
Formulation logic100
The contributing ingredients work alone or have their supporting partners, and their amounts qualify. No ingredient conflict was identified.
Partner coverage
No additional supporting partner is missing for the contributing ingredients.
Conflicts
No ingredient conflict was identified among the evaluated ingredients.
Effective doses
Every ingredient counted as a contributor has a qualifying amount.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 supports cellular energy production, with limited evidence for fatigue relief that depends on the preparation and population studied. Clinical-cohort findings do not establish routine energy benefits in healthy adults. Its included serving receives amount support, without proving an absorption advantage or a guaranteed response.
How this product is rated for Energy
Ingredient fit93
The relevant included ingredients are Coenzyme Q-10. Their amounts receive different levels of support in the supplied findings.
Goal fit
The relevant ingredients dominate the assessed formulation, although the product is also linked to other goals.
Dose adequacy
The included amounts reach the saved amount references; this does not establish added benefit from larger intakes.
Pathways60
The supplied findings concentrate on cellular energy production. They do not establish broad coverage across the other configured energy pathways.
Depth
The best-represented configured pathway is cellular energy production.
Breadth
Only cellular energy production reaches the saved breadth requirement; other configured pathways do not.
Evidence95
The strongest included evidence contribution comes from Coenzyme Q-10. Preparation matching does not remove the ingredient-specific limits on fatigue benefits.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence contribution, subject to its specific population and deficiency limitations.
Studied preparation
The included preparations meet the saved study check, without establishing that the finished product itself was tested.
Formulation logic100
The counted ingredients meet the minimum amount requirement, without a missing required partner or matched conflict.
Partner coverage
No included ingredient lacks a required partner in the supplied findings; this does not imply extra benefit from combining ingredients.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount requirement, which is distinct from a proven fatigue-treatment dose.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 participates in mitochondrial energy processes, but this product’s ubiquinol form does not match the ubiquinone regimen behind the supplied anti-inflammatory evidence. That small disease-specific trial found a TNF-alpha difference while endpoint CRP and IL-6 were unchanged. The saved amount finding does not establish preparation equivalence or routine clinical benefit.
How this product is rated for Inflammation
Ingredient fit93
Coenzyme Q-10 contributes to the saved ingredient-fit finding. The retained amount reaches its reference comparison.
Goal fit
The ingredients retained for this goal and the product’s other active ingredients and linked uses determine its focus.
Dose adequacy
The retained amount reaches the saved reference level; this does not establish an effective clinical anti-inflammatory dose.
Pathways59
The strongest recorded connection concerns oxidative and mitochondrial stress. Coverage remains concentrated in one tracked pathway.
Depth
The strongest recorded connection concerns oxidative and mitochondrial stress, without establishing the size of a clinical benefit.
Breadth
Only one tracked pathway reached the saved coverage threshold, leaving the recorded coverage narrow.
Evidence63
Coenzyme Q-10 leads the saved evidence finding. The supplied findings concern limited or inconsistent biomarker outcomes rather than established routine clinical benefit.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; the supplied population and biomarker limitations still restrict claims of clinical benefit.
Studied preparation
The retained CoQ10 form does not match the studied ubiquinone preparation, so the amount comparison cannot establish equivalent effects.
Formulation logic100
The retained ingredients have no missing required partner or configured conflict and meet the minimum amount criterion. These findings do not establish synergy.
Partner coverage
No missing required partner was identified for the retained ingredients; this does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this finding does not establish overall safety or individual suitability.
Effective doses
All retained ingredients meet the saved minimum amount criterion; that criterion is not a proven effective clinical dose.
Impact
High effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 helps cells transfer energy through their mitochondria, but this normal role does not establish that supplementation raises whole-body energy expenditure. The supplied metabolic-control findings address a different outcome from thermogenesis. The declared amount contributes to the saved comparison, without establishing sustained metabolic-rate or weight-loss effects. The form does not establish a superior thermogenic benefit.
How this product is rated for Metabolism Support
Ingredient fit93
Coenzyme Q-10 contributes to the saved ingredient and amount findings. The supplied scientific context limits expectations for a direct metabolism boost.
Goal fit
The formula contains no unrelated active ingredients diluting those included in this comparison.
Dose adequacy
The included amounts reach the full comparison allowances; these are not proven thermogenic doses.
Pathways54
The included routes emphasize mitochondrial energy and fat oxidation. One reaches the coverage threshold.
Depth
The strongest included route concerns mitochondrial energy and fat oxidation; this does not establish a direct rise in calorie expenditure.
Breadth
One route meets the coverage threshold; broader thermogenic effects are not established.
Evidence75
Coenzyme Q-10 leads the included evidence finding. Cellular energy roles and metabolic biomarkers do not by themselves demonstrate higher whole-body energy expenditure.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, while its supplied findings do not establish a routine energy-expenditure boost.
Studied preparation
The included preparations are accepted for comparison; this does not establish that the product reproduces a thermogenesis trial.
Formulation logic100
No missing partner or configured conflict is identified. Meeting comparison amounts does not establish added thermogenesis from the formula.
Partner coverage
The supplied findings identify no missing partner needed by the included ingredients.
Conflicts
No configured ingredient conflict is identified in the supplied formula; this is a limited interaction check.
Effective doses
The included ingredients meet the minimum amount threshold, which does not establish an effective thermogenic dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ubiquinol | 200 mg |
Coenzyme Q-10 · 200 mg OverallScore89
The evaluation identifies ubiquinol and lists 200 mg of CoQ10 per serving. The whole-product price is about $0.55 per serving.
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
The evaluation identifies ubiquinol, although the saved source is unmapped. The saved facts do not identify a specialized delivery system or black pepper enhancer covered by the evaluation.
Molecular Form: Ubiquinol vs. Ubiquinone
The evaluation identifies ubiquinol, although the saved source is unmapped.
Formulation & Absorption Enhancers
The saved facts do not identify a specialized delivery system or black pepper enhancer covered by the evaluation.
Dose, Safety & Label Transparency100
Each serving lists 200 mg of CoQ10. The amount is individually disclosed.
Clinical Dosage Alignment
The listed amount is 200 mg of CoQ10 per serving.
Label Transparency & Fillers
The amount is disclosed, and the evaluation does not flag the specified additives or standard fillers.
Value100
The whole-product price works out to about $0.27 per 100 mg of CoQ10, a relatively low rate for ubiquinol in the evaluation.
Price Per Effective Serving
The whole-product price works out to about $0.27 per 100 mg of CoQ10, a relatively low rate for ubiquinol in the evaluation.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.